David McDermott, MD, from Beth Israel Deaconess Medical Center in Boston, MA, debates the role of ipilimumab for clear cell renal cancer with Uromigos host Brian Rini, MD. Dr. McDermott debates that the role of ipilimumab is increasingly important, while Dr. Rini believes that its importance is diminishing.